Kidney failure: aims for the next 10 years and barriers to success.

Autor: Remuzzi G; IRCCS-Istituto di Ricerche Farmacologiche Mario Negri, Bergamo, Italy. giuseppe.remuzzi@marionegri.it, Benigni A, Finkelstein FO, Grunfeld JP, Joly D, Katz I, Liu ZH, Miyata T, Perico N, Rodriguez-Iturbe B, Antiga L, Schaefer F, Schieppati A, Schrier RW, Tonelli M
Jazyk: angličtina
Zdroj: Lancet (London, England) [Lancet] 2013 Jul 27; Vol. 382 (9889), pp. 353-62. Date of Electronic Publication: 2013 May 31.
DOI: 10.1016/S0140-6736(13)60438-9
Abstrakt: Although in some parts of the world acute and chronic kidney diseases are preventable or treatable disorders, in many other regions these diseases are left without any care. The nephrology community needs to commit itself to reduction of this divide between high-income and low-income regions. Moreover, new and exciting developments in fields such as pharmacology, genetic, or bioengineering, can give a boost, in the next decade, to a new era of diagnosis and treatment of kidney diseases, which should be made available to more patients.
(Copyright © 2013 Elsevier Ltd. All rights reserved.)
Databáze: MEDLINE